PSPraveen Sharma

Praveen Sharma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Praveen Sharma has a total of 156 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • HOOK3::FGFR1 Fusion in a Background of FGFR1 Amplification in Childhood B‐Cell Acute Lymphoblastic Leukemia

    by Aishwarya Karthikeyan, Venus Thakur, Himangi Tak, Shailja Rathore, Anshu Anshu, Praveen Sharma, Richa Jain, Sreejesh Sreedharanunni

  • Fine‐Needle Aspiration Cytology of Gingival Acute Promyelocytic Leukemia: Cytomorphologic Clues to an Unusual Extramedullary Presentation

    by Aravind Radhakrishnan, Kaustabh Adhikari, Praveen Sharma, Nabhajit Mallik, Arihant Jain, Parikshaa Gupta

    Introduction: Acute promyelocytic leukemia (APL) is a hematologic emergency in which prompt diagnosis is essential to reduce early hemorrhagic mortality. Although oral manifestations are well recognized in acute myeloid leukemia, gingival infiltration is distinctly uncommon in APL, and concomitant central nervous system (CNS) involvement at presentation is exceptionally rare. As gingival lesions may be sampled during their diagnostic evaluation, recognition of characteristic cytomorphology on fine‐needle aspiration cytology (FNAC) can provide an early clue to the underlying hematologic malignancy. Case: A 30‐year‐old man presented with excessive post‐tooth‐extraction bleeding, diffuse gingival enlargement, and left facial palsy. FNAC of the gingival swelling demonstrated scattered abnormal hypergranular promyelocytes with folded nuclei, multiple Auer rods, and occasional faggot cells in a hemorrhagic background, strongly suggestive of APL. Subsequent peripheral blood flow cytometry, bone marrow examination, and molecular testing confirmed PML::RARA ‐positive APL. Cerebrospinal fluid cytology and flow cytometry established concurrent CNS involvement. Treatment with all‐trans retinoic acid and arsenic trioxide resulted in hematologic remission and complete resolution of the gingival enlargement. Conclusions: This case highlights the diagnostic value of gingival FNAC in the rapid identification of uncommon extramedullary presentations of APL. Knowledge of the characteristic cytomorphologic features facilitates early diagnosis and timely initiation of the life‐saving differentiation therapy.

  • Open Access

    VEXAS syndrome: a comprehensive clinicopathologic and genetic analysis of a predominantly Indian cohort

    by Dheeraj Chinnam, Aadya Kerkar, Rohit Gulati, Prateek Bhatia, Sreejesh Sreedharanunni, Praveen Sharma, Minu Singh, Shikha Shah, Narayanan Baskaran, Ramya Puligari, et al.

    Background: VEXAS syndrome is a recently recognized, acquired monogenic adult onset hemato-inflammatory syndrome characterized by somatic mutations within the UBA1 gene. The acronym VEXAS stands for vacuoles, E1 enzyme, X-linked inheritance, autoinflammatory tendencies, and somatic mutations. It presents as a severe progressive disease displaying varied characteristics that bridge hematologic and rheumatologic domains. Herein, we describe a series with a detailed evaluation of 11 cases of VEXAS syndrome. Materials and methods: A comprehensive retrospective analysis of patients diagnosed with VEXAS syndrome over the last 5 years (2020–2025) was conducted. Data on clinical presentation, histopathological findings, genetic characteristics, and outcomes were recorded for systematic characterization. Results: A total of 11 cases of VEXAS syndrome were identified. All the patients were males with an age range from 42 to 77 years. Prominent clinical characteristics included history of fever (11), arthritis/arthralgia (10), inflammatory skin lesions (7), vasculitis (6), ocular inflammatory conditions (6), relapsing polychondritis (6), unprovoked venous thrombosis (5), and auricular chondritis (4). Persistent unexplained cytopenia was present in all the patients, manifesting as anemia (10, 8 of which were macrocytic), thrombocytopenia (4), and neutropenia (2). Bone marrow examination was performed in nine cases, five showed morphologic dysplasia. Furthermore, all nine cases characteristically showed cytoplasmic vacuolations in hematopoietic precursors. UBA1 somatic mutations included p.Met41Thr (c.122 T>C Exon 3) (55%), p.Met41Val (c.121 A>G Exon 3) (27%), p.Met41Leu (c.121 A>C Exon 3) (9%), and a variant in the acceptor splice site of Exon 3 (c.118 G>C) (9%). p.Met41Val is associated with inferior overall survival (OS). Conclusion: This study characterizes the clinical, morphologic, and laboratory features of VEXAS syndrome and presents the first comprehensive patient cohort from India. With a complex and heterogeneous clinical profile, awareness of the disease is particularly essential among hematologists, rheumatologists, and dermatologists for accurate diagnosis and management.

  • Predictors of response to botulinum toxin treatment in patients with primary hemifacial spasm: A prospective cohort study

    by Sneh Jain, Shweta Pandey, Ravindra Kumar Garg, Rajesh Verma, Hardeep Singh Malhotra, Anit Parihar, Praveen Kumar Sharma, Neeraj Kumar, Ravi Uniyal, Imran Rizvi, et al.

  • KMT2A amplification in acute myeloid leukemia post cytotoxic therapy: an entity with dismal prognosis

    by Shruti Madan, Arushi Sharma, Hari Neupane, Praveen Sharma, Sreejesh Sreedharanunni, Shano Naseem, Aditya Jandial, Pankaj Malhotra

  • Flow Cytometric Intracellular 5‐Methyl Cytosine Expression and Its Correlation With Cytogenetics and Measurable Residual Disease in Adult B‐Lineage Acute Lymphoblastic Leukemia

    by Sreejesh Sreedharanunni, Prabhjot Kaur, Sudhanshi Raina, Parveen Bose, Arun Kumar, Praveen Sharma, Shano Naseem, Arihant Jain, Alka Khadwal, Man Updesh Singh Sachdeva


  • Open Access

    BoMBR: An Annotated Bone Marrow Biopsy Dataset for Segmentation of Reticulin Fibers

    by Panav Raina, Satyender Dharamdasani, Dheeraj Chinnam, Praveen Sharma, Sukrit Gupta

    Bone marrow reticulin fibrosis is associated with varied benign as well as malignant hematological conditions. The assessment of reticulin fibrosis is important in the diagnosis, prognostication and management of such disorders. The current methods for quantification of reticulin fibrosis are inefficient and prone to errors. Therefore, there is a need for automated tools for accurate and consistent quantification of reticulin. However, the lack of standardized datasets has hindered the development of such tools. In this study, we present a comprehensive dataset that comprises of 201 Bo ne M arrow B iopsy images for R eticulin (BoMBR) quantification. These images were meticulously annotated for semantic segmentation, with the focus on performing reticulin fiber quantification. This annotation was done by two trained hematopathologists who were aided by Deep Learning (DL) models and image processing techniques that generated a rough automated annotation for them to start with. This ensured precise delineation of the reticulin fibers alongside other cellular components such as bony trabeculae, fat, and cells. This is the first publicly available dataset in this domain with the aim to catalyze advancements the development of computational models for improved reticulin quantification. Further, we show that our annotated dataset can be used to train a DL model for a multi-class semantic segmentation task for robust reticulin fiber detection task (Mean Dice score: 0.92). We use these model outputs for the Marrow Fibrosis (MF) grade detection and obtained a Mean Weighted Average F1 score of 0.656 with our trained model. Our code for preprocessing the dataset is available at https://github.com/AI-in-Medicine-IIT-Ropar/BoMBR_dataset_preprocessing .


  • Open Access

    Coexistence of BCR::ABL1 translocation and JAK2V617F mutations in indian patients with myeloproliferative neoplasms: A case series

    by Durgadevi Sundaresan, Debadrita Ray, Amarjot Kaur, Charanpreet Singh, Nithye Parvathy, Alpesh Kapadia, Riju Rani Deka, Narender Kumar, Jogeshwar Binota, Pankaj Malhotra, et al.

    BCR::ABL1 translocation and JAK2V617F mutations are canonical variants of myeloproliferative neoplasms (MPNs). Traditionally considered mutually exclusive, they may rarely coexist. We report the clinicopathological profile and treatment outcomes of four MPN patients with coexistence of these disease-defining genetic variants. Both mutations were detected simultaneously in three patients who did not harbor tell-tale signs of CML and were evaluated for both BCR::ABL1 and JAK2V617F based on clues from hemogram, peripheral-blood and bone-marrow examination. All were treated with imatinib and hydroxyurea and attained major molecular response after 2–7 months. In another patient, JAK2V617F was detected 15 years after the diagnosis of CML at the time of evaluation of loss of hematological and molecular response. She was treated with dasatinib but no hematologic or molecular response was attained after 6 months despite good compliance. In conclusion, BCR::ABL1 and JAK2V617F may rarely coexist in MPN with variable temporal evolution, clinicopathological profile, and treatment response.

  • Clinicopathological and Immunophenotypic Characteristics of Series of ZNF384 Re-arranged Acute Leukemias

    by Tharageswari Srinivasan, Praveen Sharma, Man Updesh Singh Sachdeva, Srinivasan Peyam, Lekshmon Ks, Alka Khadwal, Sreejesh Sreedharanunni

    Rearrangement involving ZNF384 gene (ZNF384-r) is recently being described in acute leukemias. We present the clinic-pathological and immunophenotypic findings in a series of five cases of acute leukemia with ZNF384-r reported in our Institute between September 2020 to September 2023. Notably, while TCF3::ZNF384 fusion was the most frequently encountered abnormality, the fusion partner was not identified in two patients with ZNF384-r BCP-ALL. Immunophenotypically, patients presenting as B-cell precursor acute lymphoblastic leukemia (BCP-ALL) had a distinct profile characterized by weak or absent CD10 expression and the presence of myeloid markers such as CD13/CD33. Our findings underscore the importance of recognizing the distinct immunophenotypic features of ZNF384-r leukemias, particularly in cases presenting with atypical BCP-ALL or B/Myeloid mixed phenotype acute leukemia phenotypes. Moreover, these findings highlight the necessity for tailored diagnostic algorithms in clinical laboratories to facilitate the timely and accurate diagnosis of this clinically relevant leukemia subtype.